Discover the World News Forecast . . . FIRST in Foresight Journalism

Maria Sharapova drug suspension ends early

April 26, 2017 - SWITZERLAND

Maria Sharapova won a six-month reduction in her two-year suspension from competitive tennis, which was her punishment for testing positive for meldonium at the 2016 Australian Open.

Players have weighed in on whether she should receive wildcards to play in upcoming tournaments, with Andy Murray in the against camp.

She appealed against the two-year suspension to the Court of Arbitration for Sport in Lausanne, Switzerland. The court ruled that the original penalty, handed down on Jun 8, 2016, was disproportionately harsh for an infraction that Sharapova had committed unintentionally.

Recently banned by anti-doping regulators, meldonium is a heart medication.

Had she not successfully challenged the original punishment, her positive test after the Australian Open would have kept her out of tennis until Jan 25, 2018.

The International Tennis Federation announced the revised suspension on Oct 4, adding that the results and prize money Sharapova earned at the 2016 Australian Open remain disqualified.

Maria Sharapova's reduced ban is good news for her bank balance (Guardian 4 Oct 2016)

CAS decision in the case of Maria Sharapova (4 Oct 2016)

TF statement regarding the case of Maria Sharapova (ITF 6 Oct 2016)

Should Maria Sharapova be given a French Open wildcard? (Sports Illustrated 8 Mar 2017)

Infographic: Sharapova returns to tennis (Graphic News)

Date written/update: 2016-12-15